Cigna price target lowered to $360 from $415 at Raymond James

Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares. Cigna’s Q4 results were significantly below expectations, and EPS for 2025 is expected to be below the company’s 10%-14% long-term adjusted EPS algorithm, the analyst tells investors in a research note. It has become apparent that the managed care complex has limited visibility when cost trend is changing rapidly and Cigna has struggled to capture these changes in plan pricing over the last 1-2 years, the firm says.